Dynavax Technologies Corporation


Company Update (NASDAQ:DVAX): Dynavax Technologies Corporation Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) and Updates Financial Status

Dynavax Technologies Corporation (NASDAQ:DVAX) announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically reviewing safety data from HBV-23, the ongoing …

Looking Ahead in Biotech: Ariad Pharmaceuticals, Inc. (ARIA), Dynavax Technologies Corporation (DVAX), OncoGenex Pharmaceuticals Inc (OGXI)

Biotechnology companies release data on pipeline drug studies up update analysts and investors on the progress of a drug. Positive data releases have …

MLV Reiterates Upbeat View Of Dynavax Technologies Following DSMB’s 2nd Recommendation

MLV’s healthcare analyst Vernon Bernardino came out with a few insights on Dynavax Technologies Corporation (NASDAQ:DVAX), after the company’s independent Data and Safety Monitoring Board (DSMB) has …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts